---
figid: PMC9257764__etm-24-02-11421-g02
pmcid: PMC9257764
image_filename: etm-24-02-11421-g02.jpg
figure_link: /pmc/articles/PMC9257764/figure/f3-ETM-24-2-11421/
number: Figure 3
figure_title: ''
caption: FXR signaling pathway in dyslipidemia. FXR regulates lipid metabolism by
  inhibiting CYP7A1 expression. Arrows represent stimulatory modifications. T-shaped
  arrows represent inhibitory modifications. The picture was generated using Adobe
  Illustrator CC version 23.0 (Adobe Systems, Inc.). BA, bile acids; FXR, farnesoid
  X receptor; SHP, small heterodimer partner; LRH-1, liver receptor homolog-1; JNK,
  c-Jun N-terminal kinase; FGFR4, fibroblast growth factor receptor 4; FGF15, fibroblast
  growth factor 15; CYP7A1, cholesterol 7 alpha-hydroxylase; FXRE, farnesoid X response
  element.
article_title: Research progress of signaling pathways of the natural substances intervene
  dyslipidemia (Review).
citation: Ningning Cao, et al. Exp Ther Med. 2022 Aug;24(2):494.
year: '2022'

doi: 10.3892/etm.2022.11421
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- dyslipidemia
- signaling pathway
- lipid metabolism
- research progress

---
